Teva Pharmaceuticals USA is voluntarily recalling 224,604 cartons of Mimvey (estradiol and norethindrone acetate) tablets because the products were mislabeled. Mimvey is a prescription hormone replacement therapy used to treat symptoms of menopause. No incidents or injuries have been reported to date, but the medication was distributed to pharmacies nationwide across the United States.
The mislabeling of these prescription tablets could cause confusion regarding dosage or administration instructions, which may result in a patient taking the medication incorrectly. While the recall is considered low risk, patients should verify their medication with their healthcare provider to ensure they are using the correct product.
You have 2 options:
Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454
Manufactured By: Barr Laboratories, Inc., Pomona, NY 10970; Manufactured For: Teva Pharmaceuticals USA Inc. North Wales, PA 19454
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.